ヘルスケア

バイオテクノロジーと医薬品 In the complex word of investments, JR Capital experts provide the investment community with a unique partnership to identify and qualify bio-pharmaceutical investment opportunities.  Our strength is in the analysis of cross border scientific, regulatory, intellectual property and other related components of investment target.
Our business strategy is designed for maximizing clinical and commercial potential of our product portfolio with our global platform.  Through our approach, we have created a pipeline of marketed products and development-stage assets that we believe will provide us and our partners with diversified long-term revenue stream.


医療機器 For the past ten years, JR Capital has been an innovative play to help funding entrepreneurs to grow their business in medical devices business.  We are actively in the segments of IVD, hemodialysis center, neurosurgery supplies, orthopedic implant and ophthalmic supplies. 


ヘルスケアサービス JR Capital is one of the industry leaders in privatizing stated owned hospitals in China.  JR Capital has invested into and helped to build a number of specialist chain hospitals in the field of ophthalmology, orthopaedic and rehabilitation.  As an investment banking firm, JR Capital has advised more than 10 hospitals to become public listed entities.
このウェブサイトでは、お客様の利便性を高めるためにクッキーを使用しています。お客様がこれに同意しているものとしますが、ご希望であればオプトアウトすることができます。 さらに詳しく
お問い合わせはこちらからお願いします。 お問い合わせ